advertisement

---

Zhang K 12

Showing records 1 to 12 | Display all abstracts from Zhang K

112313 Retinal Ganglion Cell Fate Induction by Ngn-Family Transcription Factors
Zhang K
Investigative Ophthalmology and Visual Science 2023; 64: 32

---

112006 Cost-utility analysis of commonly used anti-glaucoma interventions for mild-to-moderate primary open-angle glaucoma patients in rural and urban China
Li R
BMJ open 2023; 13: e073219

---

112313 Retinal Ganglion Cell Fate Induction by Ngn-Family Transcription Factors
Cai W
Investigative Ophthalmology and Visual Science 2023; 64: 32

---

112006 Cost-utility analysis of commonly used anti-glaucoma interventions for mild-to-moderate primary open-angle glaucoma patients in rural and urban China
Zhang K; Lu Z
BMJ open 2023; 13: e073219

---

112313 Retinal Ganglion Cell Fate Induction by Ngn-Family Transcription Factors
Xin Y; He Q
Investigative Ophthalmology and Visual Science 2023; 64: 32

---

112006 Cost-utility analysis of commonly used anti-glaucoma interventions for mild-to-moderate primary open-angle glaucoma patients in rural and urban China
Mou D
BMJ open 2023; 13: e073219

---

112313 Retinal Ganglion Cell Fate Induction by Ngn-Family Transcription Factors
Chen C
Investigative Ophthalmology and Visual Science 2023; 64: 32

---

112006 Cost-utility analysis of commonly used anti-glaucoma interventions for mild-to-moderate primary open-angle glaucoma patients in rural and urban China
Wang J
BMJ open 2023; 13: e073219

---

112313 Retinal Ganglion Cell Fate Induction by Ngn-Family Transcription Factors
Zeng M
Investigative Ophthalmology and Visual Science 2023; 64: 32

---

112006 Cost-utility analysis of commonly used anti-glaucoma interventions for mild-to-moderate primary open-angle glaucoma patients in rural and urban China
Li H; Fan S
BMJ open 2023; 13: e073219

---

112313 Retinal Ganglion Cell Fate Induction by Ngn-Family Transcription Factors
Chen S
Investigative Ophthalmology and Visual Science 2023; 64: 32

---

112006 Cost-utility analysis of commonly used anti-glaucoma interventions for mild-to-moderate primary open-angle glaucoma patients in rural and urban China
Wang N; Liu H
BMJ open 2023; 13: e073219

---